Singapore's Temasek assets decline on China rout

It was reported that this was the sixth medical technology-related deal for Accuron Medtech Group, a division within Accuron Technologies, in the last 2

SINGAPORE: Temasek Holdings Pte’s portfolio declined for the first time in seven years as its holdings, a quarter of which are in Chinese equities, were battered by last year’s market rout.

The value of Temasek’s stakes decreased 9% to S$242bil (US$179bil) in its fiscal year ended March 31, according to the Singapore state investment firm’s annual review released yesterday. Assets fell from a record S$266bil in the prior fiscal year and dropped for the first time since the 12 months ended March 2009.